Results 21 to 30 of about 19,931 (150)

A clinical audit of thrombophilia testing in pediatric patients with acute thromboembolic events: impact on management

open access: yesBlood Advances, 2017
: Routine testing for inherited and acquired thrombophilia defects is frequently performed in pediatric patients with thromboembolic events (TEEs). No consensus guidelines exist regarding the timing of testing or the type of patients to be tested.
Chakri Gavva   +2 more
doaj   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli   +10 more
wiley   +1 more source

Assessment of Venous Thromboembolism Risk Among Patients Admitted to Intensive Care Units in Dhaka City: A Cross-Sectional Study. [PDF]

open access: yesPublic Health Chall
Nearly half of ICU patients in Dhaka City are at high risk for venous thromboembolism by Padua risk assessment model, yet only 28.57% of high‐risk patients received prophylaxis. Mandatory systematic risk assessment and LMWH protocols are urgently needed to close this preventable care gap.
Khan MSS   +10 more
europepmc   +2 more sources

Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind   +7 more
wiley   +1 more source

Thrombophilia and cardioembolic stroke in a young patient. A case report [PDF]

open access: yesRomanian Journal of Medical Practice, 2020
Thrombophilia is well known to be an important risk factor for venous thrombosis, but there is not enough clinical data to explain the association with arterial thrombosis.
Dana Simona CHITA   +3 more
doaj   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo   +10 more
wiley   +1 more source

Analysis of thrombophilia test ordering practices at king fahad hospital of the university

open access: yesJournal of Applied Hematology, 2023
BACKGROUND: Thrombophilia tests are widely performed but often in a nonjustified and inappropriate manner as patients are not properly selected, or test timing is not considered.
Fatimah Adel Aldawood
doaj   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar   +3 more
wiley   +1 more source

Prevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary Thrombosis Centre in Switzerland

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Thrombophilia testing remains controversial, with no standardized recommendations across patient populations. Objectives: Given the clinical significance of high-risk thrombophilia (homozygous factor V Leiden or prothrombin G20210A mutations,
Shabnam Najaf Zadeh   +8 more
doaj   +1 more source

Overview of COVID-19’s relationship with thrombophilia proteins

open access: yesTürk Biyokimya Dergisi, 2021
COVID-19 is the most devastating pandemic situation we have experienced in our age, affecting all systems. Although it affects all systems, it shows its most important effect through thrombophilia.
Aydin Suna   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy